Format

Send to

Choose Destination
J Clin Oncol. 2019 May 10;37(14):1151-1153. doi: 10.1200/JCO.19.00419. Epub 2019 Mar 22.

Augmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab.

Author information

1
1 University of Rochester, Rochester, NY.
PMID:
30901301
DOI:
10.1200/JCO.19.00419

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center